CureVac and GSK will receive $740 million and single-digit royalties on COVID-19 vaccine sales in the U.S. going forward.

As part of Sanner’s strategic transformation into a Contract Development and Manufacturing Organization (CDMO) for medical ...

Intas Pharmaceuticals in collaboration with its global Accord brand subsidiaries, has acquired UDENYCA (pegfilgrastim-cbqv) ...

Minghui Pharmaceutical ( Minghui ), a late-stage clinical biopharmaceutical company, announced the closing of a $131 million ...

Emerging therapies targeting GD2, a marker highly expressed in neuroblastoma, offer tremendous promise. FDA-approved ...

Advarra, a provider of clinical research technology, expanded its Study Collaboration, a study startup technology designed to ...

Founded in 1997, VEG built its reputation through its deep engineering expertise across a range of CQV services. The ...

The expansion increases output, enhancing Axplora’s ability to meet growing global demand for high-value pharmaceutical ...

Marken's Mike Bartone, VP of Global Cold Chain Solutions Management, on scaling temperature-controlled precision logistics, ...

David King of Samsung Biologics shares insights on market demand and the technologies and capabilities needed to support ...

The Vibativ 4-Vial Starter Pak is an FDA-approved injectable antibiotic indicated to treat HABP/VABP and complicated skin and ...

Buildout includes Gerteis Macro-Pactor install to meet growing demand for complex oral solid dose development and manufacturing.